Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucopolysaccharidosis I | 12 | 2016 | 52 | 3.090 |
Why?
|
Niemann-Pick Disease, Type B | 6 | 2016 | 7 | 1.740 |
Why?
|
Iduronidase | 7 | 2016 | 31 | 1.630 |
Why?
|
Gaucher Disease | 6 | 2023 | 110 | 1.550 |
Why?
|
Niemann-Pick Disease, Type A | 5 | 2022 | 6 | 1.540 |
Why?
|
Sphingomyelin Phosphodiesterase | 5 | 2016 | 82 | 0.950 |
Why?
|
Gangliosidoses, GM2 | 1 | 2024 | 20 | 0.940 |
Why?
|
Enzyme Replacement Therapy | 9 | 2018 | 79 | 0.900 |
Why?
|
Recombinant Proteins | 8 | 2016 | 6538 | 0.510 |
Why?
|
Rare Diseases | 2 | 2018 | 619 | 0.490 |
Why?
|
Pyrrolidines | 4 | 2020 | 340 | 0.450 |
Why?
|
Age of Onset | 4 | 2024 | 3302 | 0.440 |
Why?
|
Sandhoff Disease | 2 | 2024 | 14 | 0.420 |
Why?
|
Tay-Sachs Disease | 2 | 2024 | 20 | 0.420 |
Why?
|
Disease Progression | 6 | 2024 | 13505 | 0.400 |
Why?
|
Chromosome Deletion | 5 | 2013 | 1387 | 0.340 |
Why?
|
Registries | 15 | 2017 | 8458 | 0.320 |
Why?
|
Bardet-Biedl Syndrome | 3 | 2003 | 50 | 0.310 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2017 | 819 | 0.310 |
Why?
|
Antibodies | 1 | 2016 | 2421 | 0.300 |
Why?
|
Quality of Life | 3 | 2024 | 13308 | 0.290 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2013 | 1311 | 0.280 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2008 | 187 | 0.280 |
Why?
|
Child | 43 | 2024 | 79799 | 0.260 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2006 | 346 | 0.250 |
Why?
|
Intraoperative Complications | 1 | 2012 | 1186 | 0.240 |
Why?
|
DiGeorge Syndrome | 1 | 2006 | 185 | 0.240 |
Why?
|
Abnormalities, Multiple | 6 | 2015 | 1415 | 0.240 |
Why?
|
Child, Preschool | 29 | 2020 | 42056 | 0.230 |
Why?
|
Developmental Disabilities | 2 | 2013 | 1504 | 0.230 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 659 | 0.230 |
Why?
|
Glycosaminoglycans | 5 | 2016 | 605 | 0.230 |
Why?
|
Physical Endurance | 1 | 2006 | 363 | 0.220 |
Why?
|
De Lange Syndrome | 1 | 2023 | 21 | 0.220 |
Why?
|
Hyperargininemia | 1 | 2003 | 12 | 0.220 |
Why?
|
Point Mutation | 1 | 2008 | 1594 | 0.220 |
Why?
|
Glucosylceramides | 1 | 2023 | 28 | 0.220 |
Why?
|
Motor Skills | 1 | 2006 | 520 | 0.210 |
Why?
|
Adolescent | 30 | 2024 | 87809 | 0.210 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2022 | 49 | 0.200 |
Why?
|
Growth Disorders | 3 | 2020 | 653 | 0.200 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2003 | 200 | 0.190 |
Why?
|
Mutation | 15 | 2023 | 29957 | 0.190 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2002 | 156 | 0.190 |
Why?
|
Retinal Degeneration | 2 | 2017 | 412 | 0.190 |
Why?
|
Phenotype | 17 | 2023 | 16548 | 0.180 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2024 | 258 | 0.180 |
Why?
|
Cardiomyopathies | 7 | 2010 | 1951 | 0.180 |
Why?
|
Endpoint Determination | 2 | 2018 | 597 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2020 | 114 | 0.180 |
Why?
|
Genomic Imprinting | 1 | 2002 | 330 | 0.180 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2020 | 105 | 0.180 |
Why?
|
Myocarditis | 2 | 2011 | 766 | 0.180 |
Why?
|
Angelman Syndrome | 1 | 2002 | 140 | 0.170 |
Why?
|
Glutamine | 1 | 2003 | 576 | 0.170 |
Why?
|
Histone Deacetylases | 2 | 2023 | 718 | 0.170 |
Why?
|
Adult | 29 | 2024 | 220007 | 0.170 |
Why?
|
Sphingomyelins | 2 | 2016 | 103 | 0.160 |
Why?
|
Humans | 83 | 2024 | 760613 | 0.160 |
Why?
|
Infant | 19 | 2024 | 36053 | 0.160 |
Why?
|
Disability Evaluation | 1 | 2006 | 1826 | 0.160 |
Why?
|
Metabolism, Inborn Errors | 2 | 2013 | 285 | 0.160 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1998 | 49 | 0.160 |
Why?
|
Brain Edema | 1 | 2003 | 603 | 0.160 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 49 | 0.160 |
Why?
|
Exercise Test | 1 | 2006 | 2128 | 0.150 |
Why?
|
Fatty Acid Desaturases | 1 | 1998 | 102 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17790 | 0.150 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 2013 | 127 | 0.150 |
Why?
|
Male | 53 | 2024 | 359718 | 0.150 |
Why?
|
Female | 53 | 2024 | 391246 | 0.150 |
Why?
|
Eczema | 1 | 2020 | 245 | 0.150 |
Why?
|
Mutation, Missense | 5 | 2008 | 2567 | 0.150 |
Why?
|
Hyperphosphatemia | 1 | 2017 | 39 | 0.140 |
Why?
|
Albinism, Ocular | 1 | 2017 | 7 | 0.140 |
Why?
|
Young Adult | 13 | 2024 | 58748 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2019 | 3725 | 0.140 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2018 | 186 | 0.140 |
Why?
|
Siblings | 2 | 2014 | 824 | 0.140 |
Why?
|
DNA Mutational Analysis | 10 | 2014 | 4108 | 0.140 |
Why?
|
Cost of Illness | 2 | 2024 | 1940 | 0.140 |
Why?
|
Microcephaly | 1 | 2020 | 425 | 0.140 |
Why?
|
Sequence Deletion | 5 | 2014 | 1493 | 0.140 |
Why?
|
Liver | 7 | 2020 | 7510 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 10826 | 0.130 |
Why?
|
Glucosylceramidase | 1 | 2016 | 125 | 0.130 |
Why?
|
Chelating Agents | 1 | 2017 | 384 | 0.130 |
Why?
|
Encephalocele | 1 | 2017 | 135 | 0.130 |
Why?
|
Muscular Dystrophies | 2 | 1997 | 389 | 0.130 |
Why?
|
Hyperbilirubinemia | 1 | 2015 | 74 | 0.120 |
Why?
|
Cause of Death | 3 | 2016 | 3725 | 0.120 |
Why?
|
Distal Myopathies | 1 | 2014 | 18 | 0.120 |
Why?
|
Mediator Complex | 1 | 2015 | 106 | 0.120 |
Why?
|
Apraxias | 1 | 2014 | 59 | 0.120 |
Why?
|
Orphan Drug Production | 1 | 2015 | 48 | 0.120 |
Why?
|
Genes, X-Linked | 1 | 2014 | 128 | 0.120 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 56 | 0.110 |
Why?
|
Cardiac Myosins | 1 | 2014 | 127 | 0.110 |
Why?
|
SOXC Transcription Factors | 1 | 2013 | 41 | 0.110 |
Why?
|
Rectum | 1 | 1998 | 895 | 0.110 |
Why?
|
Optic Atrophy | 1 | 2014 | 78 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2023 | 2982 | 0.110 |
Why?
|
Phosphorylcholine | 1 | 2013 | 153 | 0.110 |
Why?
|
Leigh Disease | 1 | 2014 | 89 | 0.110 |
Why?
|
Noonan Syndrome | 2 | 2012 | 120 | 0.110 |
Why?
|
X Chromosome Inactivation | 1 | 2014 | 226 | 0.100 |
Why?
|
Myosin Heavy Chains | 1 | 2014 | 402 | 0.100 |
Why?
|
Retinal Detachment | 1 | 2017 | 427 | 0.100 |
Why?
|
Heart Defects, Congenital | 2 | 2006 | 4673 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14494 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2023 | 2716 | 0.100 |
Why?
|
Interleukin-8 | 1 | 2015 | 698 | 0.100 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.100 |
Why?
|
Blood Cells | 1 | 2013 | 305 | 0.100 |
Why?
|
Sphingosine | 1 | 2013 | 308 | 0.100 |
Why?
|
Pallister-Hall Syndrome | 1 | 2010 | 4 | 0.090 |
Why?
|
X Chromosome | 3 | 2002 | 815 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8055 | 0.090 |
Why?
|
Infant, Newborn | 11 | 2016 | 26179 | 0.090 |
Why?
|
Iduronate Sulfatase | 1 | 2010 | 10 | 0.090 |
Why?
|
Milk, Human | 1 | 2015 | 483 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 4 | 2014 | 473 | 0.090 |
Why?
|
Syndactyly | 1 | 2010 | 72 | 0.090 |
Why?
|
Polydactyly | 1 | 2010 | 56 | 0.090 |
Why?
|
Middle Aged | 14 | 2024 | 220359 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2008 | 1767 | 0.090 |
Why?
|
Mucopolysaccharidosis II | 1 | 2010 | 26 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2019 | 64981 | 0.090 |
Why?
|
Eye Proteins | 1 | 2013 | 633 | 0.090 |
Why?
|
Heterozygote | 4 | 2005 | 2798 | 0.080 |
Why?
|
Speech | 1 | 2014 | 550 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2012 | 15679 | 0.080 |
Why?
|
BALB 3T3 Cells | 1 | 2008 | 10 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 4408 | 0.080 |
Why?
|
Hepatomegaly | 1 | 2008 | 84 | 0.080 |
Why?
|
Electroretinography | 2 | 2017 | 517 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5795 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2013 | 7850 | 0.080 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 2 | 1998 | 49 | 0.080 |
Why?
|
Osteochondrodysplasias | 2 | 2000 | 182 | 0.080 |
Why?
|
Glioblastoma | 1 | 2023 | 3482 | 0.080 |
Why?
|
Heart Transplantation | 5 | 2017 | 3224 | 0.080 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2008 | 116 | 0.070 |
Why?
|
Splenomegaly | 1 | 2008 | 189 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 503 | 0.070 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2007 | 43 | 0.070 |
Why?
|
Spinal Cord Diseases | 1 | 2010 | 293 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.070 |
Why?
|
Neurocutaneous Syndromes | 1 | 2007 | 53 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2235 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 363 | 0.070 |
Why?
|
Rett Syndrome | 1 | 2008 | 164 | 0.070 |
Why?
|
Time | 1 | 2009 | 545 | 0.070 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 916 | 0.070 |
Why?
|
Ghrelin | 1 | 2008 | 252 | 0.070 |
Why?
|
Lipomatosis | 1 | 2007 | 112 | 0.070 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2008 | 342 | 0.070 |
Why?
|
Chromosomes, Human, X | 1 | 2008 | 321 | 0.070 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2010 | 303 | 0.070 |
Why?
|
Breast Feeding | 1 | 2015 | 1355 | 0.070 |
Why?
|
Proteins | 4 | 2003 | 6029 | 0.070 |
Why?
|
Age Distribution | 2 | 2010 | 2893 | 0.070 |
Why?
|
Niemann-Pick Diseases | 1 | 2005 | 27 | 0.070 |
Why?
|
DNA Primers | 2 | 2008 | 2818 | 0.060 |
Why?
|
Phosphorylase Kinase | 1 | 2005 | 9 | 0.060 |
Why?
|
Glycogen Storage Disease | 1 | 2005 | 41 | 0.060 |
Why?
|
Survival Analysis | 4 | 2016 | 10185 | 0.060 |
Why?
|
Gene Deletion | 2 | 2003 | 2668 | 0.060 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2008 | 268 | 0.060 |
Why?
|
Facies | 2 | 2020 | 223 | 0.060 |
Why?
|
Transcription Factors | 4 | 2023 | 12102 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 3604 | 0.060 |
Why?
|
Biopsy | 3 | 2014 | 6771 | 0.060 |
Why?
|
Energy Metabolism | 2 | 2006 | 2869 | 0.060 |
Why?
|
Bone Diseases | 1 | 2007 | 418 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2010 | 4899 | 0.060 |
Why?
|
Echocardiography | 4 | 2017 | 4981 | 0.060 |
Why?
|
Exanthema | 1 | 2009 | 504 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4542 | 0.060 |
Why?
|
Genotype | 6 | 2011 | 12957 | 0.060 |
Why?
|
Amino Acids, Basic | 1 | 2003 | 9 | 0.060 |
Why?
|
Factor Analysis, Statistical | 1 | 2006 | 998 | 0.060 |
Why?
|
Canada | 3 | 2017 | 2126 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2290 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3839 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1722 | 0.050 |
Why?
|
Trisomy | 1 | 2004 | 260 | 0.050 |
Why?
|
Introns | 2 | 2003 | 978 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11152 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.050 |
Why?
|
Arginase | 1 | 2003 | 80 | 0.050 |
Why?
|
Syndrome | 6 | 2015 | 3280 | 0.050 |
Why?
|
Medical History Taking | 1 | 2006 | 773 | 0.050 |
Why?
|
Peroxisomal Disorders | 1 | 2002 | 12 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 323 | 0.050 |
Why?
|
Cysts | 1 | 2007 | 683 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2009 | 12427 | 0.050 |
Why?
|
Base Sequence | 3 | 2011 | 12444 | 0.050 |
Why?
|
Dark Adaptation | 1 | 2003 | 221 | 0.050 |
Why?
|
Eye Diseases | 1 | 2007 | 651 | 0.050 |
Why?
|
Transcriptional Elongation Factors | 1 | 2023 | 163 | 0.050 |
Why?
|
Ammonia | 1 | 2003 | 236 | 0.050 |
Why?
|
Muscles | 2 | 1998 | 1581 | 0.050 |
Why?
|
Codon, Nonsense | 1 | 2003 | 281 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2005 | 2852 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2003 | 377 | 0.050 |
Why?
|
Genetic Markers | 2 | 2006 | 2609 | 0.050 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2002 | 377 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2005 | 666 | 0.050 |
Why?
|
Homozygote | 2 | 2003 | 1788 | 0.050 |
Why?
|
Collagen | 2 | 2000 | 2636 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2004 | 2505 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2002 | 283 | 0.050 |
Why?
|
Risk Factors | 7 | 2017 | 74333 | 0.050 |
Why?
|
Headache | 1 | 2009 | 1249 | 0.050 |
Why?
|
Hexosaminidase A | 1 | 2020 | 1 | 0.050 |
Why?
|
Hexosaminidase B | 1 | 2020 | 1 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2942 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4571 | 0.050 |
Why?
|
Transfection | 1 | 2008 | 5781 | 0.050 |
Why?
|
Connexins | 1 | 2002 | 351 | 0.040 |
Why?
|
Transgenes | 1 | 2024 | 1006 | 0.040 |
Why?
|
Causality | 1 | 2006 | 1242 | 0.040 |
Why?
|
DNA | 1 | 2014 | 7233 | 0.040 |
Why?
|
Adrenoleukodystrophy | 1 | 2002 | 143 | 0.040 |
Why?
|
Task Performance and Analysis | 1 | 2004 | 759 | 0.040 |
Why?
|
Vision, Ocular | 1 | 2003 | 454 | 0.040 |
Why?
|
Exons | 3 | 2002 | 2389 | 0.040 |
Why?
|
Hernia, Diaphragmatic | 1 | 2000 | 246 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15840 | 0.040 |
Why?
|
Arginine | 1 | 2003 | 934 | 0.040 |
Why?
|
Prognosis | 3 | 2013 | 29661 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2005 | 1296 | 0.040 |
Why?
|
Pedigree | 5 | 2011 | 4578 | 0.040 |
Why?
|
Skin Diseases | 1 | 2007 | 1089 | 0.040 |
Why?
|
Walking | 1 | 2006 | 1190 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4925 | 0.040 |
Why?
|
Infertility, Male | 1 | 2002 | 396 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2008 | 1214 | 0.040 |
Why?
|
Motor Neurons | 1 | 2024 | 865 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2000 | 469 | 0.040 |
Why?
|
Age Factors | 3 | 2017 | 18413 | 0.040 |
Why?
|
Skin | 1 | 2012 | 4466 | 0.040 |
Why?
|
Aged | 7 | 2023 | 169143 | 0.040 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 1998 | 31 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5877 | 0.040 |
Why?
|
Deafness | 1 | 2002 | 457 | 0.040 |
Why?
|
Alleles | 3 | 2005 | 6900 | 0.040 |
Why?
|
Genetic Testing | 2 | 2004 | 3531 | 0.040 |
Why?
|
Muscle, Skeletal | 3 | 2014 | 4924 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2013 | 0.040 |
Why?
|
RNA Splicing | 2 | 1999 | 915 | 0.040 |
Why?
|
Heart Failure | 3 | 2017 | 11848 | 0.040 |
Why?
|
Mitochondria, Liver | 1 | 1998 | 190 | 0.040 |
Why?
|
Bone and Bones | 1 | 2007 | 2560 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2417 | 0.030 |
Why?
|
Infant, Newborn, Diseases | 1 | 2002 | 592 | 0.030 |
Why?
|
Myocardium | 2 | 2006 | 4700 | 0.030 |
Why?
|
Prevalence | 2 | 2010 | 15686 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5795 | 0.030 |
Why?
|
Nystagmus, Pathologic | 1 | 2017 | 105 | 0.030 |
Why?
|
Dystrophin | 1 | 1997 | 284 | 0.030 |
Why?
|
Drug Interactions | 1 | 2020 | 1428 | 0.030 |
Why?
|
Incidence | 6 | 2017 | 21391 | 0.030 |
Why?
|
Esotropia | 1 | 2017 | 99 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6238 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2000 | 551 | 0.030 |
Why?
|
Lung Diseases | 1 | 2005 | 1915 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2024 | 5782 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2004 | 1231 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1334 | 0.030 |
Why?
|
Lysosomes | 2 | 2013 | 920 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2000 | 1697 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2558 | 0.030 |
Why?
|
Haplotypes | 3 | 2011 | 2764 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1995 | 224 | 0.030 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 98 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6544 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2016 | 697 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2008 | 3976 | 0.030 |
Why?
|
Genome, Human | 2 | 2020 | 4418 | 0.030 |
Why?
|
Risk Assessment | 3 | 2013 | 24102 | 0.030 |
Why?
|
Molecular Sequence Data | 6 | 2005 | 17624 | 0.030 |
Why?
|
Muscle Hypotonia | 1 | 2015 | 160 | 0.030 |
Why?
|
Cohort Studies | 5 | 2023 | 41337 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2003 | 1801 | 0.030 |
Why?
|
Molecular Biology | 1 | 1997 | 580 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2924 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2005 | 2753 | 0.030 |
Why?
|
Prospective Studies | 5 | 2015 | 54306 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 1998 | 858 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12968 | 0.030 |
Why?
|
Legislation, Drug | 1 | 2015 | 214 | 0.030 |
Why?
|
Central Nervous System Diseases | 2 | 2007 | 521 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4286 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81209 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4035 | 0.030 |
Why?
|
Electrocardiography | 2 | 2020 | 6415 | 0.030 |
Why?
|
Spleen | 2 | 2010 | 2298 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3448 | 0.020 |
Why?
|
Fatal Outcome | 2 | 2007 | 1832 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11070 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2017 | 1516 | 0.020 |
Why?
|
Gene Frequency | 2 | 2011 | 3613 | 0.020 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4716 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2017 | 854 | 0.020 |
Why?
|
Animals | 5 | 2024 | 167960 | 0.020 |
Why?
|
Mouth Abnormalities | 1 | 2010 | 19 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14661 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 2015 | 590 | 0.020 |
Why?
|
Pilot Projects | 1 | 2004 | 8556 | 0.020 |
Why?
|
Conserved Sequence | 2 | 2005 | 1167 | 0.020 |
Why?
|
Data Collection | 1 | 2000 | 3315 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2007 | 80345 | 0.020 |
Why?
|
Muscle Proteins | 1 | 1995 | 1152 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2011 | 419 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2005 | 13451 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2014 | 39262 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 1997 | 1572 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2015 | 965 | 0.020 |
Why?
|
Alagille Syndrome | 1 | 2008 | 45 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20080 | 0.020 |
Why?
|
Craniofacial Abnormalities | 1 | 2010 | 315 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 979 | 0.020 |
Why?
|
DNA Methylation | 1 | 2002 | 4372 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2224 | 0.020 |
Why?
|
Drug Approval | 1 | 2015 | 816 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 464 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 314 | 0.020 |
Why?
|
Kidney | 1 | 2003 | 7064 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 546 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 2 | 2003 | 1078 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2014 | 15790 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 25941 | 0.020 |
Why?
|
Pregnancy | 2 | 2015 | 29746 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 965 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6831 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2635 | 0.020 |
Why?
|
Morbidity | 1 | 2011 | 1765 | 0.020 |
Why?
|
Survival Rate | 2 | 2012 | 12810 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 805 | 0.020 |
Why?
|
Japan | 1 | 2010 | 1369 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 1998 | 7022 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9591 | 0.020 |
Why?
|
Pediatrics | 1 | 2000 | 3586 | 0.010 |
Why?
|
Organ Size | 1 | 2010 | 2254 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18137 | 0.010 |
Why?
|
Mesoderm | 1 | 2007 | 672 | 0.010 |
Why?
|
Mosaicism | 1 | 2007 | 466 | 0.010 |
Why?
|
United States | 4 | 2017 | 72448 | 0.010 |
Why?
|
Gene Dosage | 1 | 2008 | 1218 | 0.010 |
Why?
|
Lipids | 1 | 2015 | 3336 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2015 | 2907 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3880 | 0.010 |
Why?
|
Research Design | 1 | 2000 | 6180 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2008 | 1067 | 0.010 |
Why?
|
Oklahoma | 1 | 2003 | 36 | 0.010 |
Why?
|
Southwestern United States | 1 | 2003 | 39 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3340 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12159 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2013 | 22052 | 0.010 |
Why?
|
Codon | 1 | 2005 | 602 | 0.010 |
Why?
|
Phylogeny | 2 | 2003 | 2775 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2005 | 565 | 0.010 |
Why?
|
Stroke Volume | 1 | 2017 | 5523 | 0.010 |
Why?
|
Chromosome Banding | 1 | 2002 | 260 | 0.010 |
Why?
|
Chemokine CCL22 | 1 | 2002 | 27 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2002 | 330 | 0.010 |
Why?
|
Cardiomegaly | 1 | 2005 | 593 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15760 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 20509 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12531 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2023 | 8985 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 410 | 0.010 |
Why?
|
Trans-Activators | 1 | 2011 | 2860 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2005 | 600 | 0.010 |
Why?
|
Peroxisomes | 1 | 2002 | 68 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 2002 | 555 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1652 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 1683 | 0.010 |
Why?
|
Twin Studies as Topic | 1 | 2000 | 104 | 0.010 |
Why?
|
Face | 1 | 2006 | 1017 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2003 | 626 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3812 | 0.010 |
Why?
|
Body Height | 1 | 2006 | 1570 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3774 | 0.010 |
Why?
|
New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8552 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4279 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2002 | 563 | 0.010 |
Why?
|
Macrophages | 1 | 2013 | 5745 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9406 | 0.010 |
Why?
|
Palmitoyl Coenzyme A | 1 | 1998 | 7 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7587 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 934 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2294 | 0.010 |
Why?
|
Trypsin | 1 | 1998 | 496 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2000 | 863 | 0.010 |
Why?
|
Myopia | 1 | 1999 | 245 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9994 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 1137 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3734 | 0.010 |
Why?
|
Zebrafish Proteins | 1 | 2002 | 1006 | 0.010 |
Why?
|
North America | 1 | 2000 | 1284 | 0.010 |
Why?
|
Cartilage | 1 | 2000 | 806 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9530 | 0.010 |
Why?
|
Glutarates | 1 | 1997 | 244 | 0.010 |
Why?
|
Acyltransferases | 1 | 1997 | 305 | 0.010 |
Why?
|
Body Weight | 1 | 2006 | 4611 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40139 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15286 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2002 | 1535 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2002 | 1264 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1693 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2003 | 1885 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6965 | 0.010 |
Why?
|
Protein Folding | 1 | 1998 | 867 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1996 | 256 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2176 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5659 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2809 | 0.010 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1999 | 781 | 0.010 |
Why?
|
Neutropenia | 1 | 1997 | 884 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1997 | 2381 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 1991 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 4089 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 15620 | 0.010 |
Why?
|
Kinetics | 1 | 1998 | 6377 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4169 | 0.010 |
Why?
|
Lymphocytes | 1 | 1997 | 2611 | 0.010 |
Why?
|
Binding Sites | 1 | 1998 | 6048 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2000 | 5201 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6065 | 0.000 |
Why?
|
Models, Molecular | 1 | 1998 | 5434 | 0.000 |
Why?
|
Brain Diseases | 1 | 1996 | 1540 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36286 | 0.000 |
Why?
|
Protein Binding | 1 | 1998 | 9335 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2000 | 12762 | 0.000 |
Why?
|